Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014

Social Media in the Pharmaceutical Industry

22 Jan 2014 - 23 Jan 2014 - London, UK

Bookmark and Share

SMi is pleased to present the 6th instalment in the sell out Social Media Pharmaceutical conference series which returns to London on 22nd and 23rd January 2014.

With health at the top of any patient’s agenda the opportunity for health professionals to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Join our panel of leading industry speakers, from Big Pharma companies to cutting edge developers at the heart of social media technology today. You simply cannot afford to miss out.

Reasons to Attend:

Learn about the cutting edge developments in social media including personalised marketing techniques, mobile platforms, remote monitoring and open stakeholder engagement.

Share ideas with leading technology providers; discuss the industry requirements and learn what technological solutions are available.

Hear how major pharmaceutical companies are actually applying the latest developments in social media in a practical way.

Analyse how social media will allow your organisation to better communicate and interact with your stakeholders.

Expert Speaker Line-up includes:

Doris Cesares, Director of Communication, AESEG

Sherri Matis-Mitchell, R and D, Astra Zeneca 

Neeraj Goel Mittal, Business Intelligence Manager, AbbVie 

Dr. Alfred R. Steinhardt, Founder, Alfred Steinhardt Consulting

Piotr Wrzosinski, Digital Marketing, Roche 

Ben Furber, Asthma UK

Claire Perrin, European Brand Leader, Eli Lilly

Alexandra Fulford, Consultant, Pharmaguapa 

Gizem Bicakci, eMarketing, Boehringer-Ingelheim 

Matt Evans, Chief Medical Officer, Health Unlocked 

Todd Kolm, Vice-President, Head of Global Digital Strategy, Sanofi

James Finney, Project Manager, Global Comm. Services, Novozymes Biopharma

Shona Davies, Communication and Programme Leader, Merck

For further details and to register, visit 

Alternatively contact John Collins on +44 (0)20 7827 6000 or email 

Join the conversation on Twitter @smigrouppharm | #pharmasocialmedia

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos